Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the
occurrence of severe hypoglycaemia during two different insulin regimens are to be
investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised
to receive analogue and human insulin for one year in random order. Outcomes will be number
of episodes of severe hypoglycaemia
Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the
occurrence of severe hypoglycaemia during two different insulin regimens are to be
investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised
to receive analogue and human insulin for one year in random order. Outcomes will be number
of episodes of severe hypoglycaemia
To purpose of this study is to compare the pharmacodynamic properties of insulin detemir,
insulin glargine and NPH insulin after a single subcutaneous injection.
To purpose of this study is to compare the pharmacodynamic properties of insulin detemir,
insulin glargine and NPH insulin after a single subcutaneous injection.
The Institute of Experimental Clinical Research, University of Aarhus
Phase 4
2005-01-01
To purpose of this study is to compare the pharmacodynamic properties of insulin detemir,
insulin glargine and NPH insulin after a single subcutaneous injection.
To purpose of this study is to compare the pharmacodynamic properties of insulin detemir,
insulin glargine and NPH insulin after a single subcutaneous injection.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
